Recent Quotes

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-12
REV		(EXPECTED)2021-08-12

Q1 2021		Est.		Actual		Surprise
EPS		-0.710		-0.660		0.0500
REV		870.000K		1.222M		352.000K

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
RAPT	RAPT Therapeutics	43.33	3.31	8.27%		1B

RAPT Therapeutics Frequently Asked Questions

How do I buy RAPT Therapeutics (RAPT) stock?

You can purchase shares of RAPT Therapeutics (NASDAQ: RAPT) through any online brokerage.

View our list of the best stock brokerages.

Who are RAPT Therapeutics's (RAPT) competitors?

Other companies in RAPT Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Syndax Pharmaceuticals (NASDAQ:SNDX), ChemoCentryx (NASDAQ:CCXI) and Mesoblast (NASDAQ:MESO).

What is the target price for RAPT Therapeutics (RAPT) stock?

The latest price target for RAPT Therapeutics (NASDAQ: RAPT) was reported by Cantor Fitzgerald on June 14, 2021. The analyst firm set a price target for 71.00 expecting RAPT to rise to within 12 months (a possible 77.41% upside). 6 analyst firms have reported ratings in the last year.

Current Stock Price for RAPT Therapeutics (RAPT)?

The stock price for RAPT Therapeutics (NASDAQ: RAPT) is $40.02 last updated Mon Jun 14 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does RAPT Therapeutics (RAPT) pay a dividend?

There are no upcoming dividends for RAPT Therapeutics.

When is RAPT Therapeutics (NASDAQ:RAPT) reporting earnings?

RAPT Therapeutics’s Q2 earnings are confirmed for after-market on August 12, 2021.

Is RAPT Therapeutics (RAPT) going to split?

There is no upcoming split for RAPT Therapeutics.

What sector and industry does RAPT Therapeutics (RAPT) operate in?

RAPT Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.